83 related articles for article (PubMed ID: 11956620)
1. Immunohistochemical expression of cytokine induced nitric oxide synthase in colorectal carcinoma.
Nozoe T; Yasuda M; Honda M; Inutsuka S; Korenaga D
Oncol Rep; 2002; 9(3):521-4. PubMed ID: 11956620
[TBL] [Abstract][Full Text] [Related]
2. [Expression of inducible nitric oxide synthase mRNA in squamous cell carcinoma of tongue].
Chen WL; Zeng SG; Li HG; Huang HZ; Pan CB
Ai Zheng; 2002 Mar; 21(3):314-8. PubMed ID: 12452003
[TBL] [Abstract][Full Text] [Related]
3. Inducible nitric oxide synthase expression and its prognostic significance in colorectal cancer.
Zafirellis K; Zachaki A; Agrogiannis G; Gravani K
APMIS; 2010 Feb; 118(2):115-24. PubMed ID: 20132175
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of inducible nitric oxide synthase for human buccal squamous-cell carcinomas: immunohistochemical, reverse transcription-polymerase chain reaction (RT-PCR) and in situ RT-PCR studies.
Chen YK; Hsue SS; Lin LM
Head Neck; 2002 Oct; 24(10):925-32. PubMed ID: 12369071
[TBL] [Abstract][Full Text] [Related]
5. [Inducible nitric oxide synthase and basic fibroblast growth factor expression as prognostic factors in supraglottic squamous cell carcinoma].
Huang Z; Zeng ZY; Peng HW; Xia LP; Hou JH
Ai Zheng; 2003 Sep; 22(9):978-81. PubMed ID: 12969533
[TBL] [Abstract][Full Text] [Related]
6. Significance of immunohistochemical expression of manganese superoxide dismutase as a marker of malignant potential in colorectal carcinoma.
Nozoe T; Honda M; Inutsuka S; Yasuda M; Korenaga D
Oncol Rep; 2003; 10(1):39-43. PubMed ID: 12469142
[TBL] [Abstract][Full Text] [Related]
7. Inducible nitric oxide synthase (iNOS) is expressed similarly in multiple aberrant crypt foci and colorectal tumors from the same patients.
Hao XP; Pretlow TG; Rao JS; Pretlow TP
Cancer Res; 2001 Jan; 61(2):419-22. PubMed ID: 11212223
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic significance of cyclin A expression in colorectal carcinoma.
Nozoe T; Inutsuka S; Honda M; Ezaki T; Korenaga D
J Exp Clin Cancer Res; 2004 Mar; 23(1):127-33. PubMed ID: 15149161
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide synthase as a marker in colorectal carcinoma.
Lagares-Garcia JA; Moore RA; Collier B; Heggere M; Diaz F; Qian F
Am Surg; 2001 Jul; 67(7):709-13. PubMed ID: 11450795
[TBL] [Abstract][Full Text] [Related]
10. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer.
Chen CN; Hsieh FJ; Cheng YM; Chang KJ; Lee PH
J Surg Oncol; 2006 Sep; 94(3):226-33. PubMed ID: 16900533
[TBL] [Abstract][Full Text] [Related]
11. Association of Ets-related transcriptional factor E1AF expression with overexpression of matrix metalloproteinases, COX-2 and iNOS in the early stage of colorectal carcinogenesis.
Nosho K; Yoshida M; Yamamoto H; Taniguchi H; Adachi Y; Mikami M; Hinoda Y; Imai K
Carcinogenesis; 2005 May; 26(5):892-9. PubMed ID: 15695237
[TBL] [Abstract][Full Text] [Related]
12. Inducible nitric oxide synthase expression in pharyngeal squamous cell carcinoma: relation to p53 expression, clinicopathological data, and survival.
Pukkila MJ; Kellokoski JK; Virtaniemi JA; Kumpulainen EJ; Johansson RT; Halonen PM; Kosunen AS; Nuutinen J; Kosma VM
Laryngoscope; 2002 Jun; 112(6):1084-8. PubMed ID: 12160278
[TBL] [Abstract][Full Text] [Related]
13. Inducible nitric oxide synthase expression, apoptosis, and angiogenesis in in situ and invasive breast carcinomas.
Vakkala M; Kahlos K; Lakari E; Pääkkö P; Kinnula V; Soini Y
Clin Cancer Res; 2000 Jun; 6(6):2408-16. PubMed ID: 10873093
[TBL] [Abstract][Full Text] [Related]
14. Expression of inducible nitric oxide synthase during cisplatin-based chemotherapy for gastric cancer.
Ikeguchi M; Ueta T; Kaibara N
In Vivo; 2002; 16(3):185-90. PubMed ID: 12182114
[TBL] [Abstract][Full Text] [Related]
15. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions.
Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M
J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148
[TBL] [Abstract][Full Text] [Related]
16. [Expression of inductive nitric oxide synthase and vascular endothelial growth factor in colonic carcinoma, and their effects on tumor angiogenesis].
Yin P; Qiu XF; Liu ZC
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Nov; 8(6):513-5. PubMed ID: 16299654
[TBL] [Abstract][Full Text] [Related]
17. Coexpression of inducible nitric oxide synthase and COX-2 in hepatocellular carcinoma and surrounding liver: possible involvement of COX-2 in the angiogenesis of hepatitis C virus-positive cases.
Rahman MA; Dhar DK; Yamaguchi E; Maruyama S; Sato T; Hayashi H; Ono T; Yamanoi A; Kohno H; Nagasue N
Clin Cancer Res; 2001 May; 7(5):1325-32. PubMed ID: 11350902
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
Lin A; Weiser MR; Klimstra DS; Paty PB; Tang LH; Al-Ahmadie H; Hoo Park S; Guillem JG; Temple L; Wong WD; Gerald WL; Shia J
Hum Pathol; 2007 Jun; 38(6):850-6. PubMed ID: 17442371
[TBL] [Abstract][Full Text] [Related]
19. The role of nitric oxide synthases and nitrotyrosine in retinoblastoma.
Adithi M; Nalini V; Krishnakumar S
Cancer; 2005 Apr; 103(8):1701-11. PubMed ID: 15754329
[TBL] [Abstract][Full Text] [Related]
20. [Expression of inducible nitric oxide synthase and basic fibroblast growth factor in supraglottic squamous cell carcinoma and their clinical significance].
Huang Z; Zeng ZY; Guan M; Xia LP
Ai Zheng; 2002 Sep; 21(9):961-4. PubMed ID: 12508542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]